<DOC>
	<DOC>NCT00721656</DOC>
	<brief_summary>To evaluate the efficacy and safety of KLS-0611 compared to placebo in patients with dry eye syndromes.</brief_summary>
	<brief_title>Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<criteria>Corneal and conjunctival damage Insufficiency of lacrimal secretion Ocular symptom Severe ophthalmic disorder Punctual plugs or surgery for occlusion of the lacrimal puncta</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Dry eye syndromes</keyword>
	<keyword>Corneal diseases</keyword>
	<keyword>Conjunctival Diseases</keyword>
</DOC>